Biomarkers such as cystatin C and neutrophil gelatinase-associated lipocalin (NGAL) have demonstrated clinical utility in detecting renal dysfunction earlier than traditional serum creatinine or urea-based assessments [4]. This evidence concerns the gene LCN2 and Abnormal renal physiology.